Related Experiment Video
Updated: Jul 26, 2025
06:26
Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
399
Inflammatory risk stratification individualizes anti-inflammatory pharmacotherapy for acute type A aortic dissection
Hong Liu1, Haiyang Li2, Lu Han3
1Department of Cardiovascular Surgery, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Innovation (Cambridge (Mass.))
|June 19, 2023
Summary
Artificial intelligence identified optimal patients for ulinastatin treatment in acute type A aortic dissection (ATAAD). This approach personalizes anti-inflammatory therapy by predicting individual risk for multiple organ dysfunction syndrome (MODS).
Area of Science:
- Cardiovascular Medicine
- Artificial Intelligence in Healthcare
- Pharmacotherapy Optimization
Background:
- Systemic benefits of anti-inflammatory drugs vary in cardiovascular diseases.
- Acute type A aortic dissection (ATAAD) management requires precise therapeutic strategies.
- Predicting multiple organ dysfunction syndrome (MODS) is crucial for patient outcomes.
Purpose of the Study:
- To apply artificial intelligence (AI) for identifying patients with ATAAD who benefit most from ulinastatin.
- To develop and validate an inflammatory risk model predicting MODS in ATAAD patients.
- To personalize anti-inflammatory treatment selection based on individual risk and treatment effect.
Main Methods:
- Utilized the Chinese multicenter 5A study database (2016-2022) with 5,126 ATAAD patients.
- Developed an AI-driven inflammatory risk model using an extreme gradient-boosting (XGBoost) algorithm.
- Validated the model's predictive performance for MODS using key clinical features.
Main Results:
- A parsimonious six-feature risk model (eGFR, leukocytes, platelets, De Ritis ratio, hemoglobin, albumin) demonstrated strong predictive ability.
- AI identified specific patient subgroups with differential benefits from ulinastatin use based on predicted MODS risk.
- Ulinastatin showed a reduced risk ratio for MODS in patients with a predicted risk between 23.5%-41.6%.
Conclusions:
- AI-driven risk stratification enables personalized selection of anti-inflammatory therapy for ATAAD patients.
- Individualized treatment strategies considering risk probability and treatment effect are essential for optimizing ulinastatin use.
- This approach highlights the need for tailoring anti-inflammatory treatment goals in ATAAD management.
Related Concept Videos
01:25Aortic Regurgitation III: Medical Management
26
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
26
01:15Aortic Regurgitation I: Introduction
19
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
19
01:26Aneurysm III: Interprofessional Care
12
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
12
01:26Atherosclerosis III: Management
15
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
15
01:22Aneurysm IV: Nursing Management
11
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
11
01:21Aneurysm II: Clinical Manifestations and Diagnostic Studies
11
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
11